Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.

Cancer letters - 31 Mar 2003

Nakayama Kentaro, Takebayashi Yuji, Nakayama Satoru, Hata Kohkichi, Fujiwaki Ritsuto, Fukumoto Manabu, Miyazaki Kohji

Abstract excerpt

A major obstacle to the treatment of ovarian carcinoma is intrinsic/acquired resistance to cisplatin-based chemotherapy. The clinical significance of p53 overexpression in patients with ovarian carcinoma is still controversial. The aim of this study was to investigate the independent prognostic significance of p53 overexpression in patients with ovarian carcinoma who are treated with cisplatin. We retrospectively...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cisplatin
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Neoplasm Staging

Share to Ovarian Neoplasms

Share to Survival Analysis

Share to Time Factors

Share to Treatment Outcome

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 12668287
DOI: 10.1016/s0304-3835(02)00686-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prognostic value of overexpression of p53 in human ovarian carcinoma patients receiving cisplatin.PMID 12668287Read ↗

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.Semantic proximity Read ↗

The prognostic significance of p53 tumor suppressor gene alterations in ovarian carcinoma.Semantic proximity Read ↗

Expression and mutation of p53 in tumor effusion cells of patients with ovarian carcinoma: response to cisplatin-based chemotherapy.Semantic proximity Read ↗

Prognostic significance of p53 mutation and p53 overexpression in advanced epithelial ovarian cancer: a Gynecologic Oncology Group Study.Semantic proximity Read ↗

p53 alterations are predictive of chemoresistance and aggressiveness in ovarian carcinomas: a molecular and immunohistochemical study.Semantic proximity Read ↗

miR-7 expression in serous ovarian carcinomas.Semantic proximity Read ↗

Sensitization of p53-mutated epithelial ovarian cancer to CD95-mediated apoptosis is synergistically induced by cisplatin pretreatment.Semantic proximity Read ↗

A comparative study of p53 gene mutations, protein accumulation, and response to cisplatin-based chemotherapy in advanced ovarian carcinoma.Semantic proximity Read ↗

The p53 Upregulated Modulator of Apoptosis (PUMA) Chemosensitizes Intrinsically Resistant Ovarian Cancer Cells to Cisplatin by Lowering the Threshold Set by Bcl-xL and Mcl-1Semantic proximity Read ↗

Critical evaluation of p53 as a prognostic marker in ovarian cancerSemantic proximity Read ↗

p53 mutations and expression in ovarian cancers: correlation with overall survival.Semantic proximity Read ↗

Expression of factors involved in regulation of DNA mismatch repair- and apoptosis pathways in ovarian cancer patientsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.